ABSTRACT A radiotracer technique has been used to assess aerosol delivery from a pressurised metered dose inhaler, used both with and without a 10 cm cylindrical spacer attachment (Syncroner), which has an open section in its upper surface. The radionuclide technetium-99m (99mTc) was added to sodium cromoglycate in a canister (Intal inhaler; 1 mg/puff); in vitro studies with a multistage liquid impinger showed that the radiolabel acted as a marker for the presence of drug over a wide range of particle sizes. Ten healthy volunteers were studied after they had inhaled from (1) a metered dose inhaler alone (slow inhaled flow rate, about 25 1/min); (2) metered dose inhaler plus spacer (slow flow rate); and (3) metered dose inhaler plus spacer (fast inhaled flow rate, about 100 1/min). Inhalation was coordinated with firing the spray and was followed by 10 seconds' breath holding. With the metered dose inhaler alone a mean 11 0% (SEM 1.4%) of the dose reached the lungs, compared with significantly higher doses for slow (16 1% (2-2%)) and fast (13-3% (1 7%)) inhalations through the spacer. The distribution pattern within the lungs was significantly more peripheral after slow inhalation. Oropharyngeal deposition was halved by the spacer. The open spacer should teach patients good coordination and delivers more aerosol to the lungs than a correctly used metered dose inhaler.
Introduction
Pressurised metered dose inhalers are used to deliver the prophylactic agent sodium cromoglycate, in addition to the more commonly used bronchodilators and topical corticosteroids.' Many patients have a poor inhaler technique, however, and may fail to derive full benefit from these drugs.2 Poor coordination between firing the metered dose inhaler and inhalation is a major problem,34 which may be overcome in various ways-for example, by using a nebuliser, dry powder inhaler, or breath actuated metered dose inhaler. by ultraviolet spectrophotometer (Pye Unicam) at a wavelength of 326 nm. The contents of the same sodium cromoglycate metered dose inhalers were then radiolabelled as described above, and the impinger measurements repeated. The radioactivity on actuator, spacer, throat, impaction stages, and filter was determined by a General Electric 400 T gamma camera connected on line to a Nodecrest data processing system, regions of interest being drawn round each zone. After 48 hours' decay the amount of sodium cromoglycate at each location within the impinger system was determined by spectrophotometric assay.
SUBJECTS
Radioaerosol studies were performed in 10 normal volunteers (six male, four female), whose ages ranged from 20 to 47 years. All the subjects were free of respiratory symptoms; forced expiratory volume in one second (FEV,) ranged from 82% to 108% predicted, and maximum expiratory flow rate at 50% forced vital capacity from 64% to 115% predicted. Six subjects were current smokers (range 1-5 pack years), though four smoked less than five cigarettes daily. Each subject gave informed consent in writing, and the studies were approved by both the ethical practices subcommittee of the hospital and the Administration of Radioactive Substances Advisory Committee.
STUDY PROTOCOL
Three radioaerosol studies were performed on three study days in a randomised order: (1) In each study the metered dose inhaler was placed in a shielded Perspex jig containing a solenoid, which was used by an observer to actuate a single dose from the metered dose inhaler while the subject took a deep inhalation from functional residual capacity to total lung capacity, with the lips closed round the inhaler mouthpiece. This was followed by 10 seconds' breath holding followed by exhalation via a filter (Inspiron 002290). The inhalation technique for the metered dose inhaler alone has been shown to optimise delivery to the lungs." During inhalation from the spacer a specially designed hood was placed over the open section, and air was drawn through the hood at 10 1/min into a further filter to collect any aerosol lost from the open part of the spacer; in vitro tests showed that withdrawing air from the open section of the spacer at this rate did not alter the amount of drug available from the spacer mouthpiece. Inhalation flow 708 rate and volume were measured by respiratory inductance plethysmography (Respitrace Corporation).
Immediately after inhalation, a posterior-anterior view of the lungs and stomach (100 seconds) and a right lateral view of the oropharynx (30 seconds) were obtained by gamma camera. Counts were corrected for attenuation of gamma rays by tissue during their passage to the detector'2 with correction factors that depended on each subject's chest dimensions. On a single occasion subjects inhaled krypton-81m ("mKr) gas from a generator (Medical Research Council Cyclotron Unit) to obtain a posterior-anterior ventilation scan. Subsequently, the 20% contour of the ventilation scan was superimposed on the aerosol image to delineate the lung edges on the latter, and regions of interest'2 were drawn on the aerosol view around central, intermediate, and peripheral lung zones (fig 2) . Activity detected in mouth, pharynx, oesophagus, and stomach was added and attributed to aerosol deposited in the oropharynx. The percentages of the dose deposited on the actuator and spacer and that lost from the open part of the spacer and recovered from the exhaled air filter were determined by comparing count rates with those from a calibration dose actuated into a beaker of water, two small scintillation probes being used. That part of the dose not accounted for in these samples was assumed to be in the subject and was divided into lung and oropharyngeal fractions according to the gamma camera counts.
The radiation dose to the lungs from three inhalations of 99Tc and a single inhalation of`mKr was estimated as 200 pGy (20 mrad pharynx, apparatus, exhaled air, and the open part of the spacer is shown in table 2, and typical deposition patterns are shown in figure 2 . Deposition in the whole lung was significantly greater with both fast and slow inhalation via the spacer than with the metered dose inhaler alone (p < 005). Deposition in the oropharynx was less with the spacer than with the standard metered dose inhaler (p < 0 05), though deposition on the apparatus was greater (p < 0 05). Significantly more aerosol was deposited in the oropharynx with fast than with slow inhalation through the spacer (p < 0 05). Deposition patterns with slow inhalations (via both metered dose inhaler and spacer) were significantly more peripheral than with fast inhalation via the spacer (p < 0 05), the mean (SEM) ratio of peripheral zone activity to central zone activity being 1-37 (0-13) for inhaler alone, 1.34 (0-11) for spacer with slow inhalation, and 0-81 (0 13) for spacer with fast inhalation. There was a trend towards a greater percentage The distribution of radioaerosol between lungs, oro-MDI-metered dose inhaler. (table 2) with slow inhalation through the spacer, but this was not significant. Both total and regional lung depositions were similar for the four non-smokers and for the six smokers.
Inhaled flow rates averaged 26-1 (SEM 4-1) 1/min for the metered dose inhaler alone, 23-8 (2 1) 1/min for slow inhalations through the spacer, and 105-3 (11-7) 1/min for fast inhalations through the spacer. Inhaled volumes were similar for the inhaler alone (2 07 (0-31) 1) and for slow inhalations through the spacer (2 05 (0-31) 1), but were higher for fast inhalations through the spacer (2-73 (0-32) 1).
Discussion
The distribution of aerosol between lungs (mean 11 -0%), oropharynx, actuator, and exhaled air was similar to that observed previously in our laboratories for a correctly used metered dose inhaler when particles of Teflon, labelled with 9'Tc, were inhaled from pressurised canisters containing placebo." 14 Other radiotracer techniques have given a similar fractionation of the dose.'"'7 The technique used in this study is a simpler method of labelling metered dose inhalers than the use of Teflon particles, requiring less specialised equipment, and the measurements reflect actual drug deposition rather than the deposition ofan inert analogue. There was a close correlation between quantities of drug and radiolabel in different size bands, so that the radiolabel acted as a marker for the presence of the drug. The use of the open spacer device reduced oropharyngeal deposition as observed previously with other models of spacers or holding chambers. '8 21 Oropharyngeal deposition was higher with fast inhalation through the spacer, as has been observed with inhalation from a metered dose inhaler alone," but this was compensated for by smaller losses on the apparatus and from the open part of the spacer. Whether inhalation through the spacer was fast or slow, deposition in the lungs was greater than after an inhalation from a metered dose inhaler alone with a slow inhalation. Several studies looking at other devices have shown that when similar inhalations are made through a metered dose inhaler and a spacer plus metered dose inhaler deposition in the lungs is enhanced with the latter. These have included studies on a 10 cm tube extension to the inhaler mouthpiece,22 a 750 ml cone shaped spacer (Nebuhaler)'922 and a 600 ml collapsable spacer (InspirEase).2022
The more central deposition patterns within the lungs observed with fast inhalation through the spacer (despite the fact that these fast breaths were also inhaled more deeply) are in agreement with measurements using either polystyrene particles23 or iron oxide particles24 inhaled by tidal breathing, as impaction in large central airways is enhanced with fast inhalation. The more central deposition was countered, however, by better delivery to the whole lung than with a metered dose inhaler alone, so that the percentage of the dose in the peripheral lung zone was not reduced. Deposition patterns in patients with obstructive airways disease might differ from those observed here in normal subjects, though Spiro et al 16 found similar total and regional depositions of pressurised aerosol in the lungs of normal subjects and patients with chronic bronchitis.
The "open" spacer differs from most other spacers currently available, because it is not possible to fire the spray into the spacer and to inhale the contents of the 709 710 spaeer subsequently. Good coordination is essential with the open spacer to prevent loss of the entire dose, though a small percentage of the dose appears to be always lost from the spacer even during coordinated inhalations, particularly those at a slow flow rate. The open spacer may prove useful for teaching correct use of a sodium cromoglycate inhaler; once coordination with the spacer has been mastered, whole lung and peripheral lung deposition at least as great as those from a correctly used metered dose inhaler may be attained irrespective of the speed of inhalation. Rapid inhalation is a common error when a standard metered dose inhaler is used,2927 resulting in reduced drug delivery" '5 and clinical efficacy28 29; but the open spacer appears to permit fast inhalation. The current study was performed in normal subjects, however, and further studies in asthmatic patients are required to determine more precisely the role of the open spacer in clinical practice.
